These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4028296

  • 1. Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors, IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013).
    Nishi T, Tabusa F, Tanaka T, Shimizu T, Nakagawa K.
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1140-7. PubMed ID: 4028296
    [No Abstract] [Full Text] [Related]

  • 2. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y, Tani T, Kanbe T, Watanabe K.
    Arzneimittelforschung; 1985 Mar; 35(7A):1144-9. PubMed ID: 4074426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS, Somani P, Freimer EH.
    Clin Ther; 1989 Mar; 11(5):640-51. PubMed ID: 2629724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical effects of oral cilostazol on suppression of platelet function in patients with cerebrovascular disease.
    Yasunaga K, Mase K.
    Arzneimittelforschung; 1985 Mar; 35(7A):1186-8. PubMed ID: 4074431
    [Abstract] [Full Text] [Related]

  • 10. Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. III. N-cyclohexyl-N-(2-hydroxyethyl)-4-(1,2-dihydro-2-oxo-6-quinolyloxy)-butyramide and related compounds.
    Nishi T, Tabusa F, Tanaka T, Ueda H, Shimizu T, Kanbe T, Kimura Y, Nakagawa K.
    Chem Pharm Bull (Tokyo); 1983 Mar; 31(3):852-60. PubMed ID: 6883608
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 2,2'-Dithiodibenzamides as inhibitors of blood platelet aggregation.
    Yamada K, Niino H, Hashimoto T, Shuto K, Nakamizo N, Kubo K, Ono T, Nakamizo A, Murayama Y.
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1214-20. PubMed ID: 4028301
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
    Ferroni R, Milani L, Simoni D, Orlandini P, Guarneri M, Franzé D, Bardi A.
    Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.